Skip to main content
Eli Lilly10-Q: Inflation impact

Lower realized prices for Mounjaro & Zepbound offset strong volume growth, especially in China.

What happened

Despite surging demand, Lilly's revenue is being impacted by lower realized prices for its blockbuster drugs, driven by inclusion in China's National Reimbursement Drug List (NRDL) and U.S. price reductions. This creates pressure to optimize costs and maximize efficiency across the business.

Source

SEC EDGARAug 5, 2026

Quarterly report (Form 10-Q)

Eli Lilly 10-Q

Filing excerpt

Outside the U.S. for the three and six months ended June 30, 2026, the volume increase was driven by Mounjaro, and the lower realized prices were primarily driven by the addition of Mounjaro to the National Reimbursement Drug List (NRDL) in China.

sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htmRead the full source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Inflation impact

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
06/30
Filed
Aug 5, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
59478
Accession number
0000059478-26-000081
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Efficiency tools needed
Signal category
Operations

Topics and mentions

Regions named

  • China
  • U.S.

Extraction

Confidence
High
Relevance
80%
Sentiment
Negative
Detected
Aug 11, 2026
signal_type
sec-10q
signal_subtype
inflationImpact

Use this data

Get every 10-Q signal for Eli Lilly and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Eli Lilly this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/07588410-345f-4d55-a965-99836dff2d88 returns this record as JSON. POST /v1/companies/enrich returns every signal for lilly.com.

{
  "signal_id": "07588410-345f-4d55-a965-99836dff2d88",
  "signal_type": "sec-10q",
  "signal_subtype": "inflationImpact",
  "detected_at": "2026-08-11T08:09:31.99+00:00",
  "company": {
    "name": "Eli Lilly",
    "domain": "lilly.com"
  },
  "data": {
    "detail": "Despite surging demand, Lilly's revenue is being impacted by lower realized prices for its blockbuster drugs, driven by inclusion in China's National Reimbursement Drug List (NRDL) and U.S. price reductions. This creates pressure to optimize costs and maximize efficiency across the business.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "Lower realized prices for Mounjaro & Zepbound offset strong volume growth, especially in China.",
    "excerpts": "Outside the U.S. for the three and six months ended June 30, 2026, the volume increase was driven by Mounjaro, and the lower realized prices were primarily driven by the addition of Mounjaro to the National Reimbursement Drug List (NRDL) in China.",
    "relevance": 0.8,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm",
    "filing_date": "2026-08-05",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "06/30",
    "sales_relevance": "Efficiency tools needed",
    "signal_category": "operations",
    "regions_mentioned": [
      "China",
      "U.S."
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.